BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 23317985)

  • 21. [Pseudoglucagonoma syndrome. Case report, therapeutic possibilities and hypotheses on the etiology].
    Ossowski B; Baum C
    Hautarzt; 1995 Mar; 46(3):173-6. PubMed ID: 7759243
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Necrolytic migratory erythema and pancreatic glucagonoma.
    Rodríguez G; Vargas E; Abaúnza C; Cáceres S
    Biomedica; 2016 Jun; 36(2):176-81. PubMed ID: 27622478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Necrolytic migratory erythema associated with fatty liver disease and the psuedoglucagonoma syndrome.
    Fuller C; Glick J; Rivas S; Burris K
    Dermatol Online J; 2016 Sep; 22(9):. PubMed ID: 28329615
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Necrolytic Migratory Erythema: A Forgotten Paraneoplastic Condition.
    Tremblay C; Marcil I
    J Cutan Med Surg; 2017; 21(6):559-561. PubMed ID: 28662584
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Necrolytic migratory erythema: a common cutaneous clue of uncommon syndromes.
    Stavropoulos PG; Papafragkaki DK; Avgerinou G; Papafragkakis H; Katsavou A; Katsambas AD
    Cutis; 2013 Nov; 92(5):E1-4. PubMed ID: 24343217
    [No Abstract]   [Full Text] [Related]  

  • 26. Necrolytic migratory erythema with myelodysplastic syndrome without glucagonoma.
    Technau K; Renkl A; Norgauer J; Ziemer M
    Eur J Dermatol; 2005; 15(2):110-2. PubMed ID: 15757825
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current knowledge in inflammatory dermatopathology.
    Fung MA; Barr KL
    Dermatol Clin; 2012 Oct; 30(4):667-84, vii. PubMed ID: 23021053
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Resolution of necrolytic migratory erythema with somatostatin analogue in a patient diagnosed with pancreatic glucagonoma.
    Saavedra C; Lamarca A; Hubner RA
    BMJ Case Rep; 2019 Aug; 12(8):. PubMed ID: 31401568
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Migratory necrolytic erythema and glucagonoma.
    Echenique-Elizondo M; Elorza JL; De Delas JS
    Surgery; 2003 Apr; 133(4):449-50. PubMed ID: 12717367
    [No Abstract]   [Full Text] [Related]  

  • 30. Necrolytic migratory erythema: an important sign of glucagonoma.
    Cui M; Wang R; Liao Q
    Postgrad Med J; 2021 Mar; 97(1145):199. PubMed ID: 32527759
    [No Abstract]   [Full Text] [Related]  

  • 31. Necrolytic migratory erythema associated with a metastatic neuroendocrine tumor.
    Lolis MS; Krishtul A; Vidal C; Shim-Chang H; Phelps R; Lebwohl M
    Cutis; 2011 Feb; 87(2):78-80. PubMed ID: 21416773
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Necrolytic migratory erythema in a patient with a glucagonoma].
    Demirbas M; Prens B
    Ned Tijdschr Geneeskd; 2021 Oct; 165():. PubMed ID: 34854628
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pseudoglucagonoma syndrome: Description of an 'Idiopatic' case.
    Ferrara G; Ingordo I; Ingordo V
    Australas J Dermatol; 2020 Nov; 61(4):e403-e405. PubMed ID: 32383170
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Octreotide (SMS 201-995) in the treatment of metastatic glucagonoma: report of one case and review of the literature.
    Rosenbaum A; Flourie B; Chagnon S; Blery M; Modigliani R
    Digestion; 1989; 42(2):116-20. PubMed ID: 2548911
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A patient with long-standing skin lesions. Necrolytic migratory erythema.
    Netea RT; Erceg A; Pieters G; Hermus AR
    Neth J Med; 2004 Dec; 62(11):453, 462. PubMed ID: 15685896
    [No Abstract]   [Full Text] [Related]  

  • 36. [Necrolytic migratory erythema revealing glucagonoma syndrome].
    Maouni S; Elanzi W; Sqalli A; Elmeknassi I; Meziane M; Benzekri L; Hassam B; Senouci K
    Ann Dermatol Venereol; 2019 May; 146(5):419-421. PubMed ID: 30910336
    [No Abstract]   [Full Text] [Related]  

  • 37. Necrolytic migratory erythema in a patient with neuroendocrine carcinoma.
    Gronau M; Jäger D; Enk AH; Hassel JC
    Intern Med; 2013; 52(1):151-2. PubMed ID: 23291692
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emergency pancreatic resection for glucagonoma associated with severe necrolytic migratory erythema.
    Daly DM; Thompson B; Low J; Slater J; Wood G; Kamath V; Haghighi KS
    ANZ J Surg; 2019 May; 89(5):599-602. PubMed ID: 28982222
    [No Abstract]   [Full Text] [Related]  

  • 39. Glucagonoma syndrome associated with necrolytic migratory erythema.
    Cardoso Filho Fde A; Feitosa RG; Fechine CO; Matos CM; Cardoso AL; Cardoso DL
    Rev Assoc Med Bras (1992); 2015; 61(3):203-6. PubMed ID: 26248239
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glucagonoma-related necrolytic migratory erythema.
    Bosch-Amate X; Riera-Monroig J; Iranzo Fernández P
    Med Clin (Barc); 2020 Nov; 155(9):418-419. PubMed ID: 31515063
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.